Drug Information

Drug General Information
Drug ID
D07OAD
Former ID
DNCL002383
Drug Name
GO-203-2c
Indication Late-stage solid tumors [ICD9: 140-199, 210-229; ICD10:C00-C75, C7A, C7B, D10-D36, D3A] Phase 1/2 [524854]
Company
Genus Oncology
Target and Pathway
Target(s) Mucin 1 Target Info Inhibitor [550809]
WikiPathways Hematopoietic Stem Cell Differentiation
References
Ref 524854ClinicalTrials.gov (NCT02204085) A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia. U.S. National Institutes of Health.
Ref 550809Clinical pipeline report, company report or official report of Genus Oncology.